Moreover, silencing of Brca2 in cancer cells is sufficient to induce Clu expression in CAFs of mouse tumors and in WT PSCs in culture, confirming not only that Clu is induced by BRCA deficiency but also that this is a non-cell-autonomous pathway induced by BRCA deficiency in the cancer cells. Here, BRCA2 is linked to cancer.